1760 Share Price Performance
Recent 1760 News & Updates
No updates
Panion & Bf Biotech Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 1.27
- Gross Margin
- 52.30%
- Net Profit Margin
- 5.41%
- Debt/Equity Ratio
- 36.1%
Panion & Bf Biotech Inc. Competitors
About 1760
- Founded
- 1974
- Employees
- n/a
- CEO
- WebsiteView website
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, and health care products in Taiwan, the United States, China, Hong Kong, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, Covid-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services. Panion & Bf Biotech Inc. was founded in 1974 and is headquartered in Taipei, Taiwan.
Taiwanese Market Performance
- 7 Days: 0.6%
- 3 Months: 12.7%
- 1 Year: 2.4%
- Year to Date: 2.3%
Over the last 7 days, the market has remained flat, although notably the Energy sector gained 9.2% in that time. Similarly, the market is flat for the past 12 months. Looking forward, earnings are forecast to grow by 13% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading